Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Industry 2016 Deep Research Report
- QYR565107
- 162 Pages
- April 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Glucagon like peptide-1 (GLP-1) agonists market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Glucagon like peptide-1 (GLP-1) agonist industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 252 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview 1
1.1 Definition and Specifications of Glucagon like peptide-1 (GLP-1) agonists 1
1.1.1 Definition of Glucagon like peptide-1 (GLP-1) agonists 1
1.1.2 Specifications of Glucagon like peptide-1 (GLP-1) agonists 2
1.2 Classification of Glucagon like peptide-1 (GLP-1) agonists 2
1.2.1 Exenatied 4
1.2.2 Liraglutide 5
1.2.3 Lixisenatide 5
1.2.4 Abliglutide 6
1.2.5 Dulaglutide 7
1.3 Applications of Glucagon like peptide-1 (GLP-1) agonists 8
1.3.1 Hospital 9
1.3.2 Pharmacy 9
1.4 Industry Chain Structure of Glucagon like peptide-1 (GLP-1) agonists 10
1.5 Industry Overview and Major Regions Status of Glucagon like peptide-1 (GLP-1) agonists 10
1.5.1 Industry Overview of Glucagon like peptide-1 (GLP-1) agonists 10
1.5.2 Global Major Regions Status of Glucagon like peptide-1 (GLP-1) agonists 11
1.6 Industry Policy Analysis of Glucagon like peptide-1 (GLP-1) agonists 12
1.7 Industry News Analysis of Glucagon like peptide-1 (GLP-1) agonists 12
2 Manufacturing Cost Structure Analysis of Glucagon like peptide-1 (GLP-1) agonists 14
2.1 Raw Material Suppliers Analysis of Glucagon like peptide-1 (GLP-1) agonists 14
2.2 Equipment Suppliers Analysis of Glucagon like peptide-1 (GLP-1) agonists 14
2.3 Labor Cost Analysis of Glucagon like peptide-1 (GLP-1) agonists 15
2.4 Other Costs Analysis of Glucagon like peptide-1 (GLP-1) agonists 18
2.5 Manufacturing Cost Structure Analysis of Glucagon like peptide-1 (GLP-1) agonists 18
2.6 Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists 19
3 Technical Data and Manufacturing Plants Analysis 21
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2015 21
3.2 Manufacturing Plants Distribution of Global Key Glucagon like peptide-1 (GLP-1) agonists Manufacturers in 2015 21
3.3 R&D Status and Technology Source of Global Glucagon like peptide-1 (GLP-1) agonists Key Manufacturers in 2015 22
4 Capacity, Production and Revenue Analysis of Glucagon like peptide-1 (GLP-1) agonists by Regions, Types and Manufacturers 23
4.1 Global Capacity, Production and Revenue of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 23
4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 28
4.3 Global Production and Revenue of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 34
4.4 Global Capacity, Production and Revenue of Glucagon like peptide-1 (GLP-1) agonists by Manufacturers 2011-2016 37
5 Price, Cost, Gross and Gross Margin Analysis of Glucagon like peptide-1 (GLP-1) agonists by Regions, Types and Manufacturers 43
5.1 Price, Cost, Gross and Gross Margin Analysis of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 43
5.2 Price, Cost, Gross and Gross Margin Analysis of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 47
5.3 Price, Cost, Gross and Gross Margin Analysis of Glucagon like peptide-1 (GLP-1) agonists by Manufacturers 2011-2016 51
6 Consumption Volume, Consumption Value and Sale Price Analysis of Glucagon like peptide-1 (GLP-1) agonists by Regions, Types and Applications 56
6.1 Global Consumption Volume and Consumption Value of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 56
6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 59
6.3 Global Consumption Volume and Consumption Value of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 63
6.4 Global Consumption Volume and Consumption Value of Glucagon like peptide-1 (GLP-1) agonists by Applications 2011-2016 66
6.5 Sale Price of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 69
6.6 Sale Price of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 69
6.7 Sale Price of Glucagon like peptide-1 (GLP-1) agonists by Applications 2011-2016 70
7 Supply, Import, Export and Consumption Analysis of Glucagon like peptide-1 (GLP-1) agonists 71
7.1 Supply, Consumption and Gap of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 71
7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 72
7.3 United States Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 73
7.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 74
7.5 Asia-Pacific Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 75
8 Major Manufacturers Analysis of Glucagon like peptide-1 (GLP-1) agonists 76
8.1 Novo Nordisk 76
8.1.1 Company Profile 76
8.1.2 Product Picture and Specifications 77
8.1.2.1 Product Picture and Specifications 77
8.1.3 Capacity, Production, Price, Cost, Gross and Revenue 78
8.2 AstraZeneca 79
8.2.1 Company Profile 79
8.2.2 Product Picture and Specifications 80
8.2.2.1 Product Picture and Specifications 80
8.2.2.2 Product Picture and Specifications 81
8.2.3 Capacity, Production, Price, Cost, Gross and Revenue 82
8.3 Eli Lilly 83
8.3.1 Company Profile 83
8.3.2 Product Picture and Specifications 84
8.3.2.1 Trulicity Picture and Specifications 84
8.3.3 Capacity, Production, Price, Cost, Gross and Revenue 85
8.4 GSK 87
8.4.1 Company Profile 87
8.4.2 Product Picture and Specifications 88
8.4.2.1 Product Picture and Specifications 88
8.4.3 Capacity, Production, Price, Cost, Gross and Revenue 89
8.5 Sanofi 90
8.5.1 Company Profile 90
8.5.2 Product Picture and Specifications 91
8.5.2.1 Product Picture and Specifications 91
8.5.3 Capacity, Production, Price, Cost, Gross and Revenue 92
8.6 Bristol-Myers Squibb 93
8.6.1 Company Profile 93
8.6.2 Product Picture and Specifications 94
8.6.3 Capacity, Production, Price, Cost, Gross and Revenue 95
8.7 Amylin 96
8.7.1 Company Profile 96
8.7.2 Product Picture and Specifications 97
8.7.3 Capacity, Production, Price, Cost, Gross and Revenue 98
9 marketing Trader or Distributor Analysis of Glucagon like peptide-1 (GLP-1) agonists 100
9.1 marketing Channels Status of Glucagon like peptide-1 (GLP-1) agonists 100
9.2 Traders or Distributors with Contact Information of Glucagon like peptide-1 (GLP-1) agonists by Regions 101
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Glucagon like peptide-1 (GLP-1) agonists 102
9.4 Regional Import, Export and Trade Analysis of Glucagon like peptide-1 (GLP-1) agonists 102
10 Industry Chain Analysis of Glucagon like peptide-1 (GLP-1) agonists 104
10.1 Major Raw Materials Suppliers with Contact Information Analysis of Glucagon like peptide-1 (GLP-1) agonists 104
10.2 Major Equipment Suppliers with Contact Information Analysis of Glucagon like peptide-1 (GLP-1) agonists 105
10.3 Major Consumers with Contact Information Analysis of Glucagon like peptide-1 (GLP-1) agonists 105
10.4 Supply Chain Relationship Analysis of Glucagon like peptide-1 (GLP-1) agonists 107
11 Development Trend of Analysis of Glucagon like peptide-1 (GLP-1) agonists 108
11.1 Capacity, Production and Revenue Forecast of Glucagon like peptide-1 (GLP-1) agonists by Regions and Types 108
11.1.1 Global Capacity, Production and Revenue of Glucagon like peptide-1 (GLP-1) agonists by Regions 2016-2021 108
11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 112
11.1.3 Global Capacity, Production and Revenue of Glucagon like peptide-1 (GLP-1) agonists by Types 2016-2021 118
11.2 Consumption Volume and Consumption Value Forecast of Glucagon like peptide-1 (GLP-1) agonists by Regions, Types and Applications 121
11.2.1 Global Consumption Volume and Consumption Value of Glucagon like peptide-1 (GLP-1) agonists by Regions 2016-2021 121
11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 124
11.2.3 Global Consumption Volume and Consumption Value of Glucagon like peptide-1 (GLP-1) agonists by Types 2016-2021 128
11.2.4 Global Consumption Volume and Consumption Value of Glucagon like peptide-1 (GLP-1) agonists by Applications 2016-2021 131
11.3 Supply, Import, Export and Consumption Forecast of Glucagon like peptide-1 (GLP-1) agonists 134
11.3.1 Supply, Consumption and Gap of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 134
11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 135
11.3.3 United States Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 136
11.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 136
11.3.5 Asia-Pacific Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 137
12 New Project Investment Feasibility Analysis of Glucagon like peptide-1 (GLP-1) agonists 138
12.1 New Project SWOT Analysis of Glucagon like peptide-1 (GLP-1) agonists 138
12.2 New Project Investment Feasibility Analysis of Glucagon like peptide-1 (GLP-1) agonists 138
12.2.1 Project Name 138
12.2.2 Investment Budget 139
12.2.3 Project Product Solutions 139
12.2.4 Project Schedule 139
13 Conclusion of the Global Glucagon like peptide-1 (GLP-1) agonists Industry 2016 market Research Report 141
Figure Picture of Glucagon like peptide-1 (GLP-1) agonists 1
Figure Comparison of Main Models from Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers 2
Table Specification Comparison of Different Types of Glucagon like peptide-1 (GLP-1) agonists 2
Table Use of Different Types of Glucagon like peptide-1 (GLP-1) agonists 3
Figure Global Production market Share of Glucagon like peptide-1 (GLP-1) agonists by Type in 2015 4
Figure Exenatied Picture 4
Figure Liraglutide Picture 5
Figure Lixisenatide Picture 6
Figure Abliglutide Picture 7
Figure Dulaglutide Picture 7
Table Applications of Glucagon like peptide-1 (GLP-1) agonists 8
Figure 2015 Global Glucagon like peptide-1 (GLP-1) agonists Major Applications Sales Share 8
Figure Hospital Examples 9
Figure Pharmacy Examples 9
Figure Industry Chain Structure of Glucagon like peptide-1 (GLP-1) agonists 10
Table Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers 11
Figure Global Major Regions Glucagon like peptide-1 (GLP-1) agonists Development Status in 2015 11
Table Industry Policy of Glucagon like peptide-1 (GLP-1) agonists 12
Table Industry News List of Glucagon like peptide-1 (GLP-1) agonists 12
Table Raw Material Suppliers 14
Table Equipment Suppliers 14
Figure 2014 APAC Overview of Average Monthly Labor Cost 15
Figure 2014 Americas Overview of Average Monthly Labor Cost 16
Figure 2014 EMEA Overview of Average Monthly Labor Cost 16
Figure 2010-2015 USA Employment Cost Index (ECI) 17
Figure 2010-2014 China Average Wage of Worker and Growth Rate (CNY/a) 17
Table Manufacturing Cost Structure Analysis of Glucagon like peptide-1 (GLP-1) agonists in 2015 18
Figure Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists API 19
Figure Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists Product 20
Table Capacity (K Units) and Commercial Production Date of Global Glucagon like peptide-1 (GLP-1) agonists Key Manufacturers in 2015 21
Table Manufacturing Plants Distribution of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015 21
Table R&D Status and Technology Source of Global Glucagon like peptide-1 (GLP-1) agonists Key Manufacturers in 2015 22
Table Global Capacity (K Units) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 23
Figure Global Capacity Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2011 24
Figure Global Capacity Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2015 24
Table Global Production (K Units) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 25
Figure Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2011 25
Figure Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2015 26
Table Global Revenue (M USD) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 26
Figure Global Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2011 27
Figure Global Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2015 27
Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 28
Figure Global Capacity Utilization Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 28
Figure Global Revenue (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 29
Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 29
Figure United States Capacity Utilization Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 30
Figure United States Revenue (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 30
Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 31
Figure Europe Capacity Utilization Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 31
Figure Europe Revenue (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 32
Figure Asia-Pacific Capacity (K Units), Production (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 32
Figure Asia-Pacific Capacity Utilization Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 33
Figure Asia-Pacific Revenue (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 33
Table Global Production (K Units) of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 34
Figure Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2011 34
Figure Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2015 35
Table Global Revenue (M USD) of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 35
Figure Global Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2011 36
Figure Global Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2015 36
Table Global and Major Manufacturers Capacity (K Units) of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 37
Table Global Capacity Market Share of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers 2011-2016 37
Figure Global Capacity Market Share of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015 38
Table Global and Major Manufacturers Production (K Units) of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 38
Table Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers 2011-2016 39
Figure Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2011 40
Figure Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015 40
Table Global and Major Manufacturers Revenue (M USD) of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 41
Table Global Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers 2011-2016 41
Figure Global Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2011 41
Figure Global Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015 42
Table Price (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 43
Figure Price (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2015 44
Table Cost (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 44
Figure Cost (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2015 45
Table Gross (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 45
Figure Gross (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2015 46
Table Gross Margin of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 46
Figure Gross Margin of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2015 47
Table Price (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 47
Figure Price (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Types in 2015 48
Table Cost (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 48
Figure Cost (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Types in 2015 49
Table Gross (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 49
Figure Gross (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Types in 2015 50
Table Gross Margin of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 50
Figure Gross Margin of Glucagon like peptide-1 (GLP-1) agonists by Types in 2015 51
Table Price (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Manufacturers 2011-2016 51
Figure Price (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Manufacturers in 2015 52
Table Cost (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Manufacturers 2011-2016 52
Figure Cost (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Manufacturers in 2015 53
Table Gross (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Manufacturers 2011-2016 53
Figure Gross (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Manufacturers in 2015 54
Table Gross Margin of Glucagon like peptide-1 (GLP-1) agonists by Manufacturers 2011-2016 54
Figure Gross Margin of Glucagon like peptide-1 (GLP-1) agonists by Manufacturers in 2015 55
Table Global Consumption Volume (K Units) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 56
Figure Global Consumption Volume Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2011 57
Figure Global Consumption Volume Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2015 57
Table Global Consumption Value (M USD) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 58
Figure Global Consumption Value Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2011 58
Figure Global Consumption Value Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2015 59
Figure Global Consumption Volume (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 59
Figure Global Consumption Value (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 60
Figure United States Consumption Volume (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 60
Figure United States Consumption Value (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 61
Figure Europe Consumption Volume (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 61
Figure Europe Consumption Value (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 62
Figure Asia-Pacific Consumption Volume (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 62
Figure Asia-Pacific Consumption Value (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 63
Table Global Consumption Volume (K Units) of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 63
Figure Global Consumption Volume Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2011 64
Figure Global Consumption Volume Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2015 64
Table Global Consumption Value (M USD) of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 65
Figure Global Consumption Value Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2011 65
Figure Global Consumption Value Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2015 66
Table Global Consumption Volume (K Units) of Glucagon like peptide-1 (GLP-1) agonists by Applications 2011-2016 66
Figure Global Consumption Volume Market Share of Glucagon like peptide-1 (GLP-1) agonists by Applications in 2011 67
Figure Global Consumption Volume Market Share of Glucagon like peptide-1 (GLP-1) agonists by Applications in 2015 67
Table Global Consumption Value (M USD) of Glucagon like peptide-1 (GLP-1) agonists by Applications 2011-2016 68
Figure Global Consumption Value Market Share of Glucagon like peptide-1 (GLP-1) agonists by Applications in 2011 68
Figure Global Consumption Value Market Share of Glucagon like peptide-1 (GLP-1) agonists by Applications in 2015 69
Table Sale Price (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2011-2016 69
Table Sale Price (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Types 2011-2016 69
Table Sale Price (USD/Unit) of Glucagon like peptide-1 (GLP-1) agonists by Applications 2011-2016 70
Table Global Supply, Consumption and Gap of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 (K Units) 71
Table United States Supply, Consumption and Gap of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 (K Units) 71
Table Europe Supply, Consumption and Gap of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 (K Units) 71
Table Asia-Pacific Supply, Consumption and Gap of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 (K Units) 72
Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 72
Table United States Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 73
Table United States Supply, Import, Export and Consumption of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 (K Units) 73
Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 74
Table Europe Supply, Import, Export and Consumption of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 (K Units) 74
Table Asia-Pacific Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 75
Table Asia-Pacific Supply, Import, Export and Consumption of Glucagon like peptide-1 (GLP-1) agonists 2011-2016 (K Units) 75
Table Novo Nordisk Information List 76
Figure Glucagon like peptide-1 (GLP-1) agonists Picture of Novo Nordisk 77
Table Glucagon like peptide-1 (GLP-1) agonists Specifications of Novo Nordisk 77
Table the Patent Expiry Dates for the Product 77
Table Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016 78
Figure Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units) and Growth Rate of Novo Nordisk 2011-2016 78
Figure Glucagon like peptide-1 (GLP-1) agonists Production (K Units) and Global Market Share of Novo Nordisk 2011-2016 79
Table AstraZeneca Information List 79
Figure Bydureon Picture of AstraZeneca 80
Table the Patent Expiry Dates for the Product 81
Figure Byetta Picture of AstraZeneca 81
Table Product Specification of AstraZeneca 81
Table Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016 82
Figure Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units) and Growth Rate of Novo Nordisk 2011-2016 82
Figure Glucagon like peptide-1 (GLP-1) agonists Production (K Units) and Global Market Share of Novo Nordisk 2011-2016 83
Table Eli Lilly Information List 83
Figure Trulicity Picture of Eli Lilly 84
Table Glucagon like peptide-1 (GLP-1) agonists Specifications of Eli Lilly 84
Table Trulicity Launched Date 85
Table Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly 2011-2016 85
Figure Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units) and Growth Rate of Eli Lilly 2011-2016 86
Figure Glucagon like peptide-1 (GLP-1) agonists Production (K Units) and Global Market Share of Eli Lilly 2011-2016 86
Table GSK Information List 87
Figure Glucagon like peptide-1 (GLP-1) agonists Picture of GSK 88
Table Glucagon like peptide-1 (GLP-1) agonists product specification of GSK 88
Table Glucagon like peptide-1 (GLP-1) agonists product intellectual property of GSK 89
Table Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of GSK 2011-2016 89
Figure Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units) and Growth Rate of GSK 2011-2016 89
Figure Glucagon like peptide-1 (GLP-1) agonists Production (K Units) and Global Market Share of GSK 2011-2016 90
Table Sanofi Information List 90
Figure Glucagon like peptide-1 (GLP-1) agonists Picture of Sanofi 91
Table Glucagon like peptide-1 (GLP-1) agonists Specification of Sanofi 91
Table Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2011-2016 92
Figure Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units) and Growth Rate of Sanofi 2011-2016 92
Figure Glucagon like peptide-1 (GLP-1) agonists Production (K Units) and Global Market Share of Sanofi 2011-2016 93
Table Bristol-Myers Squibb Information List 93
Figure Glucagon like peptide-1 (GLP-1) agonists Picture of Bristol-Myers Squibb 94
Table Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2011-2016 95
Figure Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units) and Growth Rate of Bristol-Myers Squibb 2011-2016 95
Figure Glucagon like peptide-1 (GLP-1) agonists Production (K Units) and Global Market Share of Bristol-Myers Squibb 2011-2016 96
Table Amylin Information List 96
Figure Glucagon like peptide-1 (GLP-1) agonists Picture of Amylin 97
Table Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amylin 2011-2016 98
Figure Glucagon like peptide-1 (GLP-1) agonists Capacity (K Units), Production (K Units) and Growth Rate of Amylin 2011-2016 99
Figure Glucagon like peptide-1 (GLP-1) agonists Production (K Units) and Global Market Share of Amylin 2011-2016 99
Figure marketing Channels of Glucagon like peptide-1 (GLP-1) agonists 100
Table Traders or Distributors with Contact Information of Glucagon like peptide-1 (GLP-1) agonists by Regions 101
Figure Ex-work Price, Channel Price and End Buyer Price of Glucagon like peptide-1 (GLP-1) agonists (USD/Unit) in 2015 102
Table Regional Import, Export, and Trade of Glucagon like peptide-1 (GLP-1) agonists (K Units) 102
Table Major Raw Materials Suppliers with Contact Information of Glucagon like peptide-1 (GLP-1) agonists 104
Table Major Equipment Suppliers with Contact Information of Glucagon like peptide-1 (GLP-1) agonists 105
Table Major Consumers with Contact Information of Glucagon like peptide-1 (GLP-1) agonists 105
Figure Supply Chain Relationship Analysis of Glucagon like peptide-1 (GLP-1) agonists 107
Table Global Capacity (K Units) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2016-2021 108
Figure Global Capacity Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2016 109
Figure Global Capacity Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2021 109
Table Global Production (K Units) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2016-2021 109
Figure Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2016 110
Figure Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2021 110
Table Global Revenue (M USD) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2016-2021 111
Figure Global Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2016 111
Figure Global Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2021 112
Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 112
Figure Global Capacity Utilization Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 113
Figure Global Revenue (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 113
Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 114
Figure United States Capacity Utilization Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 114
Figure United States Revenue (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 115
Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 115
Figure Europe Capacity Utilization Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 116
Figure Europe Revenue (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 116
Figure Asia-Pacific Capacity (K Units), Production (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 117
Figure Asia-Pacific Capacity Utilization Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 117
Figure Asia-Pacific Revenue (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 118
Table Global Production (K Units) of Glucagon like peptide-1 (GLP-1) agonists by Types 2016-2021 118
Figure Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2016 119
Figure Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2021 119
Table Global Revenue (M USD) of Glucagon like peptide-1 (GLP-1) agonists by Types 2016-2021 120
Figure Global Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2016 120
Figure Global Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2021 121
Table Global Consumption Volume (K Units) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2016-2021 121
Figure Global Consumption Volume Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2016 122
Figure Global Consumption Volume Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2021 122
Table Global Consumption Value (M USD) of Glucagon like peptide-1 (GLP-1) agonists by Regions 2016-2021 123
Figure Global Consumption Value Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2016 123
Figure Global Consumption Value Market Share of Glucagon like peptide-1 (GLP-1) agonists by Regions in 2021 124
Figure Global Consumption Volume (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 124
Figure Global Consumption Value (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 125
Figure United States Consumption Volume (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 125
Figure United States Consumption Value (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 126
Figure Europe Consumption Volume (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 126
Figure Europe Consumption Value (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 127
Figure Asia-Pacific Consumption Volume (K Units) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 127
Figure Asia-Pacific Consumption Value (M USD) and Growth Rate of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 128
Table Global Consumption Volume (K Units) of Glucagon like peptide-1 (GLP-1) agonists by Types 2016-2021 128
Figure Global Consumption Volume Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2016 129
Figure Global Consumption Volume Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2021 129
Table Global Consumption Value (M USD) of Glucagon like peptide-1 (GLP-1) agonists by Types 2016-2021 130
Figure Global Consumption Value Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2016 130
Figure Global Consumption Value Market Share of Glucagon like peptide-1 (GLP-1) agonists by Types in 2021 131
Table Global Consumption Volume (K Units) of Glucagon like peptide-1 (GLP-1) agonists by Applications 2016-2021 131
Figure Global Consumption Volume Market Share of Glucagon like peptide-1 (GLP-1) agonists by Applications in 2016 132
Figure Global Consumption Volume Market Share of Glucagon like peptide-1 (GLP-1) agonists by Applications in 2021 132
Table Global Consumption Value (M USD) of Glucagon like peptide-1 (GLP-1) agonists by Applications 2016-2021 133
Figure Global Consumption Value Market Share of Glucagon like peptide-1 (GLP-1) agonists by Applications in 2016 133
Figure Global Consumption Value Market Share of Glucagon like peptide-1 (GLP-1) agonists by Applications in 2021 134
Table Global Supply, Consumption and Gap of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 (K Units) 134
Table United States Supply, Consumption and Gap of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 (K Units) 134
Table Europe Supply, Consumption and Gap of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 (K Units) 135
Table Asia-Pacific Supply, Consumption and Gap of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 (K Units) 135
Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 135
Table United States Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 136
Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 136
Table Asia-Pacific Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Glucagon like peptide-1 (GLP-1) agonists 2016-2021 137
Table New Project SWOT Analysis of Glucagon like peptide-1 (GLP-1) agonists 138
Table Project Appraisal and Financing 139
Table New Project Construction Period 139
Table New Project Investment Feasibility Analysis of Glucagon like peptide-1 (GLP-1) agonists 139
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
